PDCD1 and lung carcinoma: Nowadays, programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICI), which unleash T lymphocyte-mediated immune responses, have become a breakthrough therapy for lung cancer.